mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.005 |
mRNA |
Pyrimethamine |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
0.005 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.006 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.007 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.007 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.008 |